Comparison of Vitamin E and L-carnitine, Separately or in Combination in Patients with Intradialytic Complications

Overview

Journal Nephrourol Mon

Publisher Brieflands

Specialty Nephrology

Date 2013 Dec 19

PMID 24350082

Citations 3

Authors

Hamid Tayebi Khosroshahi

Bohlul Habibi Asl

Afshin Habibzadeh

Parastoo Chaichi

Amin Ghanbarpour

Amir Hossein Badie

Affiliations

Soon will be listed here.

Abstract

Background: The most common complications during dialysis are hypotension and muscle cramps. There are many strategies to prevent and treat these complications.

Objectives: The aim of this study is to evaluate effects of vitamin E and L-carnitine supplementation alone and in combination on intradialytic complications.

Patients And Methods: In a prospective study, 20 patients with end stage renal disease on chronic hemodialysis that had intradialytic complications such as hypotension, muscle cramp, nausea, vomiting and headache were studied. These patients were studied in four 45 day periods, beginning with no treatment (step 1), receiving vitamin E (200 IU/d) (step 2), receiving L-carnitine (500 mg/d) (step 3) and their combination (step 4). Intradialytic complications were recorded in each step and compared between treatments.

Results: All three treatments significantly reduced frequency of muscle cramps in comparison to baseline values. Vitamin E alone and in combination with L-carnitine reduced the frequency of muscle cramps more effectively. Hypotension was significantly lower in combination therapy in comparison to baseline values and vitamin E treatment.

Conclusions: Vitamin E and L-carnitine both have comparative effects on intradialytic complications. As the combination use of vitamin E and L-carnitine could more effectively reduce the intradialytic complications, it is recommended for daily use in hemodialysis patients.

Citing Articles

The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis.

Chewcharat A, Chewcharat P, Liu W, Cellini J, Phipps E, Melendez Young J PLoS One. 2022; 17(7):e0271307.

PMID: 35834513 PMC: 9282471. DOI: 10.1371/journal.pone.0271307.

The effects of cool dialysate on quality of sleep among patients undergoing hemodialysis: A randomized clinical trial.

Ghanbarabadi R, Mirhosseini Z, Rakhshani M, Estaji Z, Rad M J Educ Health Promot. 2019; 8:56.

PMID: 31008123 PMC: 6442248. DOI: 10.4103/jehp.jehp_205_18.

Effects of Vitamin E on seizure frequency, electroencephalogram findings, and oxidative stress status of refractory epileptic patients.

Mehvari J, Motlagh F, Najafi M, Aghaye Ghazvini M, Naeini A, Zare M Adv Biomed Res. 2016; 5:36.

PMID: 27099849 PMC: 4815530. DOI: 10.4103/2277-9175.178780.

References

Tanimu D, Huraib S, Shaheen F, Hejaili F, Giles C, Pagayon V . The Effect of Vitamin E-Modified Dialyzers on Acute Intra-dialytic Symptoms: A Comparative Crossover Study. Saudi J Kidney Dis Transpl. 2007; 14(4):451-5. View

Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M . Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. Am J Kidney Dis. 1998; 32(2):258-64. DOI: 10.1053/ajkd.1998.v32.pm9708610. View

Bellinghieri G, Santoro D, Calvani M, Mallamace A, Savica V . Carnitine and hemodialysis. Am J Kidney Dis. 2003; 41(3 Suppl 1):S116-22. DOI: 10.1053/ajkd.2003.50099. View

Labonia W . L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. Am J Kidney Dis. 1995; 26(5):757-64. DOI: 10.1016/0272-6386(95)90439-5. View

El-Hennawy A, Zaib S . A selected controlled trial of supplementary vitamin E for treatment of muscle cramps in hemodialysis patients. Am J Ther. 2009; 17(5):455-9. DOI: 10.1097/MJT.0b013e3181b13c8f. View

RILEY J, Antony S . Leg cramps: differential diagnosis and management. Am Fam Physician. 1995; 52(6):1794-8. View

Bain M, Faull R, Milne R, Evans A . Oral L-carnitine: metabolite formation and hemodialysis. Curr Drug Metab. 2006; 7(7):811-6. DOI: 10.2174/138920006778520561. View

Daugirdas J . Dialysis hypotension: a hemodynamic analysis. Kidney Int. 1991; 39(2):233-46. DOI: 10.1038/ki.1991.28. View

Tisler A, Akocsi K, Borbas B, Fazakas L, Ferenczi S, Gorogh S . The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis. Nephrol Dial Transplant. 2003; 18(12):2601-5. DOI: 10.1093/ndt/gfg450. View

10.

Hurot J, Cucherat M, Haugh M, Fouque D . Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. J Am Soc Nephrol. 2002; 13(3):708-714. DOI: 10.1681/ASN.V133708. View

11.

Narita I, Iguchi S, Omori K, Gejyo F . Uremic pruritus in chronic hemodialysis patients. J Nephrol. 2008; 21(2):161-5. View

12.

Miguel A, Linares M, Perez A, Moll R, Sanchis J, Escobedo J . Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients. Nephron. 1988; 50(1):64-5. DOI: 10.1159/000185121. View

13.

Ahmad S, Robertson H, Golper T, Wolfson M, Kurtin P, Katz L . Multicenter trial of L-carnitine in maintenance hemodialysis patients. II. Clinical and biochemical effects. Kidney Int. 1990; 38(5):912-8. DOI: 10.1038/ki.1990.290. View

14.

Onem G, Aral E, Enli Y, Oguz E, Coskun E, Aybek H . Neuroprotective effects of L-carnitine and vitamin E alone or in combination against ischemia-reperfusion injury in rats. J Surg Res. 2006; 131(1):124-30. DOI: 10.1016/j.jss.2005.12.017. View

15.

Davenport A . Intradialytic complications during hemodialysis. Hemodial Int. 2006; 10(2):162-7. DOI: 10.1111/j.1542-4758.2006.00088.x. View

16.

Jesus A, Oliveira H, Paixao M, Fraga T, Barreto F, Valenca M . Clinical description of hemodialysis headache in end-stage renal disease patients. Arq Neuropsiquiatr. 2010; 67(4):978-81. DOI: 10.1590/s0004-282x2009000600003. View

17.

de los Reyes B, Navarro J, Perez-Garcia R, Liras A, Campos Y, Bornstein B . Effects of L-carnitine on erythrocyte acyl-CoA, free CoA, and glycerophospholipid acyltransferase in uremia. Am J Clin Nutr. 1998; 67(3):386-90. DOI: 10.1093/ajcn/67.3.386. View

18.

McGee S . Muscle cramps. Arch Intern Med. 1990; 150(3):511-8. View

19.

Brass E . Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients. Clin Ther. 1995; 17(2):176-85; discussion 175. DOI: 10.1016/0149-2918(95)80017-4. View

20.

Cruz D, Mahnensmith R, Perazella M . Intradialytic hypotension: is midodrine beneficial in symptomatic hemodialysis patients?. Am J Kidney Dis. 1997; 30(6):772-9. DOI: 10.1016/s0272-6386(97)90081-0. View